Interleukin-4 induced down-regulation of skin homing receptor expression by human viral-specific CD8+ T cells may contribute to atopic risk of cutaneous infection

被引:12
作者
Seneviratne, SL
Jones, L
Bailey, AS
Samuel, RV
Black, AP
Ogg, GS [1 ]
机构
[1] Univ Oxford, Weatherall Inst Mol Med, Cutaneous Immunol Grp, Oxford OX3 9DS, England
[2] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England
基金
英国医学研究理事会;
关键词
CD8(+) T cells; CLA; IL-4; IL-12;
D O I
10.1111/j.1365-2249.2005.02823.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Factors controlling the expression of cutaneous lymphocyte-associated antigen (CLA) by T cells are poorly understood, but data from murine and human CD4(+) T cell systems have suggested that cytokines play an important role. However, there are no data examining the influence of cytokines on the expression of CLA by human antigen-specific CD8(+) T cells. Peripheral blood mononuclear cells (PBMC) were isolated from 10 HLA-A*0201-positive healthy individuals. Using HLA-peptide tetrameric complexes refolded with immunodominant peptides from Epstein-Barr virus (EBV), cytomegalovirus (CMV) and influenza A virus, we investigated the temporal associations of CLA expression by viral-specific CD8(+) T cells following stimulation with antigen. Ex vivo influenza matrix-specific CD8(+) T cells expressed significantly (P < 0.05) greater levels of CLA than EBV BMLF1 and CMV pp65-specific CD8(+) T cells (mean 9.7% influenza matrix versus 1.4% BMLF1 versus 1.1% pp65) and these differences were sustained on culture. However, regardless of viral specificity, interleukin (IL)-12 and IL-4 induced significant (P < 0.05) dose-dependent up-regulation and down-regulation of CLA expression, respectively, with IL-4 showing a dominant negative effect. In many cases, IL-4 resulted in complete abrogation of detectable CLA expression by the viral-specific CD8(+) T cells. Overall these data demonstrate that CLA expression by human viral-specific CD8(+) T cells is highly dynamic and that IL-4 causes significant down-regulation. Disorders associated with a type 2 cytokine shift may reduce the efficiency of skin homing by viral-specific CD8(+) T cells. Furthermore, the ability to modify the local and systemic microenvironment may offer novel therapeutic strategies that influence tissue-specific T cell homing.
引用
收藏
页码:107 / 115
页数:9
相关论文
共 52 条
[1]  
Akdis M, 2000, EUR J IMMUNOL, V30, P3533, DOI 10.1002/1521-4141(2000012)30:12<3533::AID-IMMU3533>3.0.CO
[2]  
2-5
[3]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[4]   C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential [J].
Andrew, DP ;
Ruffing, N ;
Kim, CH ;
Miao, WY ;
Heath, H ;
Li, Y ;
Murphy, K ;
Campbell, JJ ;
Butcher, EC ;
Wu, LJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :103-111
[5]   Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections [J].
Appay, V ;
Dunbar, PR ;
Callan, M ;
Klenerman, P ;
Gillespie, GMA ;
Papagno, L ;
Ogg, GS ;
King, A ;
Lechner, F ;
Spina, CA ;
Little, S ;
Havlir, DV ;
Richman, DD ;
Gruener, N ;
Pape, G ;
Waters, A ;
Easterbrook, P ;
Salio, M ;
Cerundolo, V ;
McMichael, AJ ;
Rowland-Jones, SL .
NATURE MEDICINE, 2002, 8 (04) :379-385
[6]   Functional cutaneous lymphocyte antigen can be induced in essentially all peripheral blood T lymphocytes [J].
Armerding, D ;
Kupper, TS .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 119 (03) :212-222
[7]   Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial [J].
Bhushan, M ;
Bleiker, TO ;
Ballsdon, AE ;
Allen, MH ;
Sopwith, M ;
Robinson, MK ;
Clarke, C ;
Weller, RPJB ;
Graham-Brown, RAC ;
Keefe, M ;
Barker, JNWN ;
Griffiths, CEM .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (05) :824-831
[8]  
Biedermann T, 2002, EUR J IMMUNOL, V32, P3171, DOI 10.1002/1521-4141(200211)32:11<3171::AID-IMMU3171>3.0.CO
[9]  
2-4
[10]  
BOROWITZ MJ, 1993, LEUKEMIA, V7, P859